RTTNews·2025-10-28 04:51Group 1: Market Movements - Several healthcare and biotech stocks experienced significant gains in after-hours trading, influenced by earnings updates, executive appointments, and capital market activities [1] Group 2: Company-Specific Updates - Pulmonx Corp. (LUNG) saw a surge of 33.33% to $2.08, announcing preliminary third-quarter 2025 revenue of approximately $21.5 million and a leadership change with Glen French reappointed as President and CEO [2] - Q32 Bio Inc. (QTTB) increased by 12.5% to $3.15, although no specific news was reported to explain this rise [3] - Universal Health Services Inc. (UHS) climbed 7.41% to $229.90 after reporting third-quarter results and revising its full-year 2025 operating forecast, alongside a $1.5 billion increase in its stock repurchase program [3] - X4 Pharmaceuticals Inc. (XFOR) gained 5.35% to close at $3.94 after completing a public offering of 52.8 million shares, raising approximately $155.3 million before expenses [4] - Greenwich LifeSciences Inc. (GLSI) advanced 5.41% to $10.32 with no new developments reported [5] - Cardiff Oncology, Inc. (CRDF) moved up 5.26% to $2.41, also without any accompanying news [5]